Gilead Sciences Financials
| GILD34 Stock | BRL 287.56 4.47 1.58% |
Gilead |
Understanding current and past Gilead Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Gilead Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Gilead Sciences' assets may result in an increase in income on the income statement.
Please note, the presentation of Gilead Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gilead Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Gilead Sciences' management manipulating its earnings.
Gilead Sciences Stock Summary
Gilead Sciences competes with Merck, AbbVie, Bristol Myers, Biogen. Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company was founded in 1987 and is headquartered in Foster City, California. GILEAD DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 11000 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | 333 Lakeside Drive, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.gilead.com |
| Phone | 650 574 3000 |
| Currency | BRL - Brazilian Real |
You should never invest in Gilead Sciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Gilead Stock, because this is throwing your money away. Analyzing the key information contained in Gilead Sciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Gilead Sciences Key Financial Ratios
Gilead Sciences' financial ratios allow both analysts and investors to convert raw data from Gilead Sciences' financial statements into concise, actionable information that can be used to evaluate the performance of Gilead Sciences over time and compare it to other companies across industries.Gilead Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Gilead Sciences's current stock value. Our valuation model uses many indicators to compare Gilead Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gilead Sciences competition to find correlations between indicators driving Gilead Sciences's intrinsic value. More Info.Gilead Sciences is rated # 4 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Gilead Sciences is roughly 2.07 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Gilead Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Gilead Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Gilead Sciences Systematic Risk
Gilead Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gilead Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Gilead Sciences correlated with the market. If Beta is less than 0 Gilead Sciences generally moves in the opposite direction as compared to the market. If Gilead Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gilead Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gilead Sciences is generally in the same direction as the market. If Beta > 1 Gilead Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Gilead Sciences December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Gilead Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gilead Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gilead Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Gilead Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gilead Sciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.63 | |||
| Information Ratio | 0.1909 | |||
| Maximum Drawdown | 12.72 | |||
| Value At Risk | (2.91) | |||
| Potential Upside | 2.1 |
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |